Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Albumins | 2 | 2016 | 72 | 0.670 |
Why?
|
| Data Interpretation, Statistical | 4 | 2015 | 329 | 0.670 |
Why?
|
| Brain Ischemia | 4 | 2016 | 665 | 0.550 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2012 | 56 | 0.400 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 93 | 0.390 |
Why?
|
| Stroke | 5 | 2016 | 2163 | 0.380 |
Why?
|
| Cytokines | 1 | 2012 | 866 | 0.300 |
Why?
|
| Neuroprotective Agents | 2 | 2015 | 317 | 0.210 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 498 | 0.190 |
Why?
|
| Research Design | 3 | 2014 | 729 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2014 | 931 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2016 | 7029 | 0.160 |
Why?
|
| Nicardipine | 1 | 2016 | 21 | 0.140 |
Why?
|
| Hypertension | 2 | 2016 | 1535 | 0.130 |
Why?
|
| Chorioamnionitis | 1 | 2015 | 40 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 198 | 0.120 |
Why?
|
| Benzoates | 1 | 2014 | 20 | 0.120 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 95 | 0.120 |
Why?
|
| Medical Futility | 1 | 2014 | 31 | 0.120 |
Why?
|
| Cerebral Revascularization | 1 | 2014 | 45 | 0.120 |
Why?
|
| Blood Pressure Determination | 1 | 2014 | 152 | 0.110 |
Why?
|
| Benzimidazoles | 1 | 2014 | 128 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2014 | 182 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2014 | 87 | 0.110 |
Why?
|
| Chemokine CCL3 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2015 | 296 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 233 | 0.100 |
Why?
|
| Interleukin-12 | 1 | 2012 | 75 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 101 | 0.100 |
Why?
|
| Humans | 12 | 2016 | 68618 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2012 | 330 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2455 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 366 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 848 | 0.090 |
Why?
|
| Infant | 2 | 2015 | 2891 | 0.090 |
Why?
|
| Prognosis | 2 | 2012 | 2093 | 0.090 |
Why?
|
| Sex Factors | 1 | 2012 | 1266 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2014 | 1451 | 0.080 |
Why?
|
| Uteroglobin | 1 | 2008 | 5 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 307 | 0.060 |
Why?
|
| Female | 7 | 2016 | 38074 | 0.060 |
Why?
|
| Time Factors | 1 | 2012 | 4655 | 0.060 |
Why?
|
| Male | 6 | 2016 | 37321 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1664 | 0.060 |
Why?
|
| Brain | 1 | 2012 | 2176 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1738 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2014 | 296 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2014 | 706 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1536 | 0.040 |
Why?
|
| Aged | 4 | 2016 | 14862 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2016 | 65 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 10 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 216 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 57 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2016 | 334 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 37 | 0.030 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.030 |
Why?
|
| Sphygmomanometers | 1 | 2014 | 2 | 0.030 |
Why?
|
| White Coat Hypertension | 1 | 2014 | 4 | 0.030 |
Why?
|
| Thrombophilia | 1 | 2014 | 21 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 63 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2015 | 3705 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 69 | 0.030 |
Why?
|
| Mothers | 1 | 2015 | 172 | 0.030 |
Why?
|
| Office Visits | 1 | 2014 | 83 | 0.030 |
Why?
|
| Global Health | 1 | 2014 | 136 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 296 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 195 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 253 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 249 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 248 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 373 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 4848 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2011 | 27 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 955 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Biostatistics | 1 | 2011 | 43 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1140 | 0.020 |
Why?
|
| Middle Aged | 3 | 2016 | 21147 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 238 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 377 | 0.020 |
Why?
|
| Bias | 1 | 2011 | 148 | 0.020 |
Why?
|
| Decision Making | 1 | 2014 | 410 | 0.020 |
Why?
|
| Adult | 3 | 2014 | 21403 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2334 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1619 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2077 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Mammaglobin A | 1 | 2008 | 4 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3259 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 448 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 217 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2008 | 258 | 0.020 |
Why?
|
| Heart Failure | 1 | 2015 | 1180 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5731 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1465 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 5717 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2358 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 8912 | 0.010 |
Why?
|